Cargando…
Mutations inhibiting KDM4B drive ALT activation in ATRX-mutated glioblastomas
Alternative Lengthening of Telomeres (ALT) is a telomere maintenance pathway utilised in 15% of cancers. ALT cancers are strongly associated with inactivating mutations in ATRX; yet loss of ATRX alone is insufficient to trigger ALT, suggesting that additional cooperating factors are involved. We ide...
Autores principales: | Udugama, M., Hii, L., Garvie, A., Cervini, M., Vinod, B., Chan, F.-L., Das, P. P., Mann, J. R., Collas, P., Voon, H. P. J., Wong, L. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110556/ https://www.ncbi.nlm.nih.gov/pubmed/33972520 http://dx.doi.org/10.1038/s41467-021-22543-z |
Ejemplares similares
-
Ribosomal DNA copy loss and repeat instability in ATRX-mutated cancers
por: Udugama, Maheshi, et al.
Publicado: (2018) -
Inhibition of a K9/K36 demethylase by an H3.3 point mutation found in paediatric glioblastoma
por: Voon, Hsiao P. J., et al.
Publicado: (2018) -
Histone H3.3 phosphorylation promotes heterochromatin formation by inhibiting H3K9/K36 histone demethylase
por: Udugama, Maheshi, et al.
Publicado: (2022) -
The Role of ATRX in the Alternative Lengthening of Telomeres (ALT) Phenotype
por: Amorim, João P., et al.
Publicado: (2016) -
ATRX/DAXX: Guarding the Genome against the Hazards of ALT
por: Clatterbuck Soper, Sarah F., et al.
Publicado: (2023)